Cargando…
The Success of Ovulation Induction with Letrozole and Gonadotropins in Obese and Nonobese Women: A Study from a Tertiary Center
BACKGROUND: Letrozole, an aromatase inhibitor, is suggested as a first-line drug for ovulation induction in women with polycystic ovary syndrome (PCOS) especially in obese women. Letrozole has also been used in women with unexplained infertility with similar rates of success to clomiphene. However,...
Autores principales: | Gowri, Vaidyanathan, Al-Amri, Arwa, Almamari, Thikra Mohammed Abdulrahman, Al Khaduri, Maha, Jaju, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232370/ https://www.ncbi.nlm.nih.gov/pubmed/35756974 http://dx.doi.org/10.1155/2022/1931716 |
Ejemplares similares
-
Current evidence supporting “letrozole” for ovulation induction
por: Kar, Sujata
Publicado: (2013) -
Induction of Ovulation in the Human with Human Gonadotropins
por: Buxton, C. Lee, et al.
Publicado: (1960) -
Letrozole and human menopausal gonadotropin for ovulation induction in clomiphene resistance polycystic ovary syndrome patients: A randomized controlled study
por: Shi, Shaoquan, et al.
Publicado: (2020) -
Lessons from low-dose gonadotropin therapy for ovulation induction in polycystic ovary syndrome: Can prolonged letrozole therapy eliminate failure to respond to oral ovulation agents?
por: Paulson, Richard J.
Publicado: (2023) -
Prevalence of Tubal Obstruction in the Hysterosalpingogram of Women with Primary and Secondary Infertility
por: Al Subhi, Taimoora, et al.
Publicado: (2013)